Hana Pharm Co., Ltd. logo

Hana Pharm Co., Ltd. (293480)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
9,240. 00
+80
+0.8734%
203.79B Market Cap
- P/E Ratio
2,040% Div Yield
19,763 Volume
1,365 Eps
9,160
Previous Close
Add Transaction
Day Range
9,130 9,300
Year Range
8,780 12,500
Want to track 293480 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

293480 closed today higher at ₩9,240, an increase of 0.8734% from yesterday's close, completing a monthly decrease of -3.8502% or -₩370. Over the past 12 months, 293480 stock lost -17.6471%.
293480 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -82.0582%, based on the last three reports.
Hana Pharm Co., Ltd. has completed 1 stock splits, with the recent split occurring on Apr 28, 2021.
The company's stock is traded on one exchange.

293480 Chart

People also search for

Hyundai Motor Co.
647,000
+6.5898%
Hyundai Motor Co. Ltd.
244,500
+4.9356%
Hyundai Motor Co. Ltd. Preferred
256,500
+6.2112%
Hyundai Motor Co., Ltd. Preferred
257,000
+6.639%
Kia Corporation
167,500
+0.4197%

Hana Pharm Co., Ltd. (293480) FAQ

What is the stock price today?

The current price is ₩9,240.00.

On which exchange is it traded?

Hana Pharm Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 293480.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2,040%.

What is its market cap?

As of today, the market cap is 203.79B.

Has Hana Pharm Co., Ltd. ever had a stock split?

Hana Pharm Co., Ltd. had 1 splits and the recent split was on Apr 28, 2021.

Hana Pharm Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Taehong Choi CEO
KRX SM Exchange
KR7293480000 ISIN
KR Country
- Employees
29 Dec 2025 Last Dividend
28 Apr 2021 Last Split
- IPO Date

Overview

Hana Pharm Co., Ltd. is a distinguished player in the global pharmaceutical industry, with its roots planted firmly in South Korea. Since its inception in 1958, the company has been dedicated to the development and provision of an extensive range of pharmaceutical products. Catering to diverse health needs, Hana Pharm extends its services both domestically and internationally, reinforcing its presence with a solid foundation headquartered in the bustling city of Seoul, South Korea. This established pharmaceutical entity is at the forefront of advancing healthcare solutions, through innovation, wide-ranging product offerings, and a clear commitment to enhancing patient care and well-being.

Products and Services

Hana Pharm Co., Ltd. boasts a comprehensive portfolio of pharmaceutical products, addressing a myriad of health conditions and therapeutic areas:

  • Anesthetics: These are drugs used to induce anesthesia to temporarily block sensation, including pain, during surgical procedures. Hana Pharm provides a variety of anesthetic drugs to support surgeries and medical procedures.
  • Narcotic Analgesics: This category includes powerful pain-relieving medications that primarily affect the central nervous system to alleviate moderate to severe pain. These are carefully regulated medications due to their potential for dependency.
  • Antiemetics: Designed to prevent and treat nausea and vomiting, these medications are crucial in managing side effects of chemotherapy, radiation, and surgery, as well as other conditions that trigger these symptoms.
  • Muscle Relaxants: These drugs are employed to ease muscle spasms and discomfort, often prescribed in conjunction with rest and physical therapy to treat conditions like back pain or other muscle-related injuries.
  • Cardiovascular and Endocrine System Products: These encompass a variety of medications aimed at treating ailments associated with the heart, blood vessels, and endocrine disorders, including diabetes and thyroid conditions.
  • Gastrointestinal System Products: Focusing on drugs that affect the digestive tract, these products address issues such as acid reflux, ulcers, and other gastrointestinal disorders.
  • Respiratory System Products: This category involves treatments for diseases and conditions affecting the lungs and airways, including asthma, chronic obstructive pulmonary disease (COPD), and infections like pneumonia.
  • Antibiotics: Hana Pharm supplies a range of antibacterial drugs to combat various bacterial infections, helping to curb the spread and severity of these diseases.
  • Dermatology: This sector covers treatments for skin conditions and diseases, ranging from common issues like acne and eczema to more complex conditions such as psoriasis and skin cancer.
  • Urinology: Encompassing medications aimed at urinary tract health, these products address conditions such as urinary tract infections (UTIs), bladder issues, and kidney stones.
  • Osteoporosis: Specializing in treatments for osteoporosis, these medications help strengthen bones, reduce the risk of fractures, and manage the symptoms associated with this bone-weakening condition.
  • Central Nervous System Products: Aimed at treating disorders of the central nervous system, these include medications for neurological conditions such as epilepsy, Parkinson’s disease, and Alzheimer’s disease.
  • Analgesics, Antipyretics, and Anti-inflammatory Drugs: Providing relief from pain, fever, and inflammation, these drugs serve as pivotal treatments for a wide array of conditions, from minor ailments to chronic diseases.

Contact Information

Address: EK-Tower, Seoul, South Korea
Phone: 82 2 577 7667